Douglas T Golenbock

Title: Innovations and Contributions of Douglas T. Golenbock

Introduction

Douglas T. Golenbock is a prominent inventor based in Wellesley, MA (US). He has made significant contributions to the field of immunotherapy and fluorescent proteins. With a total of 5 patents, Golenbock's work has advanced our understanding and treatment of various pathogen infections.

Latest Patents

Among his latest patents is the "Factor H-Fc immunotherapy," which involves fusion proteins comprising human FH domains 18-20 linked to IgG Fc. This innovation includes a mutation of D to G at position 1119 in domain 19, known as FHD1119G/Fc. This patent outlines methods of using this fusion protein to treat pathogen infections. Another notable patent is for "Fluorescent proteins and related methods and compounds." This invention includes fusion polypeptides that consist of a first fluorescent protein, such as a FRET donor protein, and a second fluorescent protein, a FRET acceptor protein. The polypeptide can be immobilized with respect to a surface via the Fc-region, even in the absence of antibodies, and can serve as a calibration standard for fluorescence resonance energy transfer.

Career Highlights

Douglas T. Golenbock is affiliated with the University of Massachusetts, where he continues to contribute to research and innovation in his field. His work has garnered attention for its potential applications in medical therapies and diagnostics.

Collaborations

Golenbock has collaborated with notable colleagues, including Alberto Visintin and Eicke Latz, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Douglas T. Golenbock's innovative work in immunotherapy and fluorescent proteins exemplifies the importance of research in advancing medical science. His contributions continue to influence the field and pave the way for future discoveries.